[1]
2020. Prognostic value of pre-treatment routine hematological parameters in breast carcinoma: Advantageous or deleterious?. Biomedical Research and Therapy. 7, 8 (Aug. 2020), 3916–3920. DOI:https://doi.org/10.15419/bmrat.v7i8.621.